Tormod Nilsen | Cardiac Rehabilitation | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

 

Best Researcher Award

Tormod Nilsen
The Norwegian School of Sport Science

Tormod Nilsen
Affiliation The Norwegian School of Sport Science
Country Norway
Scopus ID 51864003400
Documents 32
Citations 1,486
h-index 17
Subject Area Cardiac Rehabilitation
Event
Cardiology and Cardiovascular Medicine
ORCID
0000-0002-9380-2808

Tormod Nilsen is a researcher affiliated with The Norwegian School of Sport Science whose academic work focuses on exercise science, cardiovascular health, rehabilitation, and clinical research. His research interests include cardiorespiratory fitness, exercise interventions, cardiovascular risk, and rehabilitation among clinical populations. These research areas connect physical activity with preventive and rehabilitative healthcare and contribute to the broader understanding of cardiovascular outcomes. His scholarly profile is represented by 32 documents, 1,486 citations, and an h-index of 17, according to the supplied researcher information.[1]

Abstract

This article presents a scholarly recognition profile of Tormod Nilsen, a researcher affiliated with The Norwegian School of Sport Science. His research is associated with exercise science, cardiovascular health, cardiac rehabilitation, and clinical research involving physical fitness and exercise interventions. His work contributes to understanding relationships between physical activity, cardiovascular function, rehabilitation, and long-term health outcomes. The supplied research profile records 32 documents, 1,486 citations, and an h-index of 17. His academic activities demonstrate interdisciplinary engagement across exercise physiology, cardiovascular medicine, rehabilitation, and related clinical research. This profile summarizes his research areas, contributions, publications, impact, and suitability for researcher recognition.[1]

Keywords

Cardiac rehabilitation; exercise science; cardiovascular health; cardiorespiratory fitness; cardiovascular medicine; rehabilitation research; exercise intervention; clinical research; physical activity; cancer survivorship.

Introduction

Research in exercise science and cardiac rehabilitation increasingly examines the relationship between physical activity, cardiovascular function, clinical risk, and long-term health. Within this interdisciplinary environment, Tormod Nilsen’s research profile is associated with exercise physiology and cardiovascular rehabilitation. His academic work contributes to research examining how structured exercise can be evaluated in relation to physiological fitness and clinical outcomes.[2]

Research Profile

Nilsen’s research profile is centered on exercise-related cardiovascular and rehabilitation questions. Cardiorespiratory fitness provides an important research measure because it can be examined in relation to physical function, cardiovascular risk, and treatment outcomes. His work also connects exercise research with clinical populations, creating an interdisciplinary research direction involving sports science, rehabilitation, cardiology, and preventive health.[3]

Research Contributions

A significant area of relevance in Nilsen’s research is the evaluation of exercise and cardiorespiratory fitness in clinical populations. Research concerning exercise dose and adherence is also important because accurate reporting of exercise exposure supports reproducibility and interpretation of intervention studies. Such methodological considerations strengthen the evidence base for exercise-based rehabilitation and clinical research.[2]

Publications

The research record associated with Nilsen includes collaborative publications addressing exercise therapy, cardiovascular toxicity, cardiorespiratory fitness, exercise dose, adherence, and rehabilitation. These publications demonstrate engagement with both methodological and clinically oriented research questions. The literature also places exercise within emerging cardiovascular and oncology research frameworks, where rehabilitation and physical fitness are increasingly investigated as components of comprehensive patient care.[3][4][5]

Research Impact

The supplied bibliometric profile reports 32 documents, 1,486 citations, and an h-index of 17. These indicators provide quantitative measures of scholarly visibility, although bibliometric values should always be interpreted according to database coverage, publication history, disciplinary citation patterns, and collaboration practices. The research themes represented in the publication record are relevant to exercise science, cardiovascular rehabilitation, and clinical health research.[1]

Award Suitability

The supplied academic profile provides several factors relevant to consideration for a Best Researcher Award in the field of cardiovascular and rehabilitation research. His reported publication activity, citation record, h-index, and research focus provide measurable indicators for evaluation. The interdisciplinary nature of his work also connects sports science with cardiovascular medicine and rehabilitation, making the profile relevant to an award emphasizing research contributions in these areas.[1]

Conclusion

Tormod Nilsen’s academic profile reflects research activity connecting exercise science, cardiovascular health, and rehabilitation. His research contributions include work concerning exercise interventions, cardiorespiratory fitness, cardiovascular outcomes, exercise methodology, and clinical rehabilitation. The supplied bibliometric information further indicates a measurable publication and citation record. Together, these elements provide an appropriate scholarly basis for consideration within a Best Researcher Award framework.[1]

References

  1. Scopus Author Profile. Tormod Nilsen — Author ID 51864003400.
    https://www.scopus.com/pages/authors/51864003400
  2. Original Article (2015.). Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy.
    https://doi.org/10.1111/sms.12543
  3. Original Article (2012.). The effect of strength training volume on satellite cells, myogenic regulatory factors, and growth factors.
    https://doi.org/10.1111/j.1600-0838.2012.01452.x
  4. ORCID. (n.d.). ORCID record:Tormod Nilsen, ORCID iD0000-0002-9380-2808.
    https://orcid.org/0000-0002-9380-2808
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

 

Emilia D’Elia | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Emilia D’Elia
ASST Papa Giovanni XXIII, Italy

Emilia D’Elia
Affiliation ASST Papa Giovanni XXIII
Country Italy
Scopus ID 40660899000
Documents 100
Citations 1,647
h-index 19
Subject Area Heart Failure
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-6682-0074

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a research profile focused on heart failure. The supplied bibliometric record reports 100 documents, 1,647 citations, and an h-index of 19, providing measurable indicators of scholarly productivity and visibility within cardiovascular medicine.[1]

Abstract

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a documented research profile in heart failure. Available bibliometric information identifies 100 documents, 1,647 citations, and an h-index of 19, indicating sustained publication activity and measurable academic visibility. Her subject specialization places her work within contemporary cardiovascular medicine, where heart failure research addresses diagnosis, treatment, outcomes, and disease management. The profile provides a quantitative basis for considering research recognition while acknowledging that bibliometric indicators should be interpreted alongside publication quality, originality, clinical relevance, collaboration, and broader contributions to cardiovascular science and patient care.[1]

Keywords

Emilia D’Elia; heart failure; cardiology; cardiovascular medicine; clinical research; scholarly impact; bibliometrics; citations; h-index; cardiovascular outcomes; ASST Papa Giovanni XXIII; Italy; research recognition; Best Researcher Award.

Introduction

Heart failure is a major area of cardiovascular research requiring evidence across prevention, diagnosis, pharmacological management, device therapy, and long-term outcomes. Contemporary clinical guidance emphasizes multidisciplinary and evidence-based approaches to improving outcomes for affected patients.[2] Researchers specializing in heart failure contribute to the development and evaluation of clinically relevant evidence.

Research Profile

The supplied profile identifies Emilia D’Elia with ASST Papa Giovanni XXIII in Italy and associates her principal subject area with heart failure. Her Scopus author identifier is 40660899000, while the reported record comprises 100 documents, 1,647 citations, and an h-index of 19. These indicators describe a research profile with established bibliometric visibility.[1]

Research Contributions

The available information supports characterization of D’Elia’s research within heart failure and cardiovascular medicine. Research in this field can contribute to understanding disease mechanisms, improving risk assessment, evaluating therapeutic strategies, and strengthening evidence-based clinical care. The documented publication and citation record provides measurable evidence of sustained engagement with the scientific literature.[1]

Publications

The supplied Scopus information reports 100 documents associated with the researcher profile. Because individual publication titles, journals, publication years, and article-level identifiers were not provided, this article does not assign specific publications or DOIs without verification. The complete bibliographic record can be reviewed through the linked Scopus author profile.[1]

Research Impact

The reported 1,647 citations and h-index of 19 provide quantitative measures of scholarly influence within the indexed research record. Citation metrics can assist in evaluating research visibility, although they do not independently establish methodological quality, originality, clinical effectiveness, or societal benefit. A balanced assessment should therefore consider both bibliometric and qualitative evidence.[1]

Award Suitability

Based on the supplied information, Emilia D’Elia presents characteristics relevant to consideration for a Best Researcher Award in cardiology and cardiovascular medicine, particularly through her documented activity in heart failure research and established bibliometric record. Final award assessment should additionally consider originality, publication quality, research leadership, clinical relevance, collaboration, and independently verifiable achievements.

Conclusion

Emilia D’Elia’s supplied academic profile reflects sustained research activity in heart failure and cardiovascular medicine, supported by 100 reported documents, 1,647 citations, and an h-index of 19. These indicators provide a quantitative foundation for academic recognition, while a complete award evaluation should incorporate verified publication quality, scientific originality, clinical significance, and broader research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Emilia D’Elia, Author ID 40660899000. Scopus.
    https://www.scopus.com/pages/authors/40660899000
  2. Journal article (2025.). SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.
    https://doi.org/10.1093/eurheartjsupp/suae117
  3. Journal article. (2026.). Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fraction.
    https://doi.org/10.1093/eschf/xvaf022
  4. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Cedric Duval | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Cedric Duval
University of Leeds

Cedric Duval
Affiliation University of Leeds
Country United Kingdom
Scopus ID 55941091300
Documents 43
Citations 1,556
h-index 21
Subject Area Cardiovascular Researches
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-4870-6542

Cedric Duval is presented as a researcher affiliated with the University of Leeds in the United Kingdom, with a stated subject area of cardiovascular research. The supplied academic profile records 43 documents, 1,556 citations, and an h-index of 21. These bibliometric indicators provide quantitative context for evaluating scholarly productivity and research visibility within cardiovascular science. [1]

Abstract

This profile presents Cedric Duval, affiliated with the University of Leeds, as a researcher working within cardiovascular research. The supplied academic indicators report 43 documents, 1,556 citations, and an h-index of 21, providing measurable evidence of publication activity and citation visibility. The profile considers these indicators alongside institutional affiliation, researcher identification information, and the proposed Best Researcher Award context. The assessment emphasizes documented scholarly output, research visibility, and relevance to cardiovascular science. Bibliometric values are presented as supplied and should be interpreted as time-sensitive indicators that may change as databases update records and citations. [1]

Keywords

Cedric Duval, cardiovascular research, cardiovascular medicine, University of Leeds, bibliometrics, scholarly publications, citation impact, h-index, research excellence, Best Researcher Award.

Introduction

Cardiovascular research encompasses scientific investigation into the mechanisms, prevention, diagnosis, treatment, and management of diseases affecting the heart and vascular system. Researchers in this field contribute through experimental studies, clinical investigations, translational research, and interdisciplinary approaches. Academic recognition commonly considers the quality and relevance of research together with evidence of scholarly productivity and influence. [2]

Research Profile

Cedric Duval is identified in the supplied information as being affiliated with the University of Leeds in the United Kingdom. The stated research subject area is cardiovascular research. The associated Scopus Author ID is 55941091300, while the supplied ORCID identifier is 0000-0002-4870-6542. Persistent researcher identifiers help distinguish scholarly records and support accurate attribution of publications across academic information systems. [1] [3]

Research Contributions

The available profile data indicate a sustained body of scholarly output, represented by 43 documents and substantial citation activity. Within cardiovascular research, contributions may be evaluated according to originality, methodological quality, scientific relevance, reproducibility, and potential clinical significance. The supplied bibliometric information provides quantitative context, while publication-level analysis would be required to establish the specific scientific findings and contributions associated with individual works. [1]

Publications

The supplied information attributes 43 documents to the researcher profile. This page does not assign individual article titles, journals, publication dates, or research findings that were not provided in the source information. The Scopus Author ID supplied for this profile can be used to review the indexed publication record, including documents, citations, co-authorship, subject classifications, and related bibliometric information. [1]

Research Impact

The supplied citation count of 1,556 and h-index of 21 indicate measurable visibility within the indexed scholarly record. Citation indicators can assist in describing research influence, although they should be interpreted alongside publication quality, field-specific citation practices, authorship contribution, and publication age. Accordingly, bibliometric measures are most appropriately treated as complementary evidence within a broader academic evaluation rather than as an independent measure of research quality. [1]

Award Suitability

Based on the supplied profile, Cedric Duval demonstrates characteristics relevant to consideration for a Best Researcher Award in cardiovascular research, including documented scholarly output, citation activity, and a stated specialization aligned with cardiovascular science. The reported 43 documents, 1,556 citations, and h-index of 21 provide quantitative evidence for consideration. Final award eligibility and selection should be determined according to the official criteria, verification procedures, and evaluation process established by the organizing body. [1] [4]

Conclusion

Cedric Duval is presented as a cardiovascular research scholar affiliated with the University of Leeds. The supplied bibliometric information records 43 documents, 1,556 citations, and an h-index of 21, providing a concise quantitative profile of scholarly activity. These indicators support consideration within an academic recognition framework, while a complete assessment should incorporate publication quality, research originality, contribution to cardiovascular science, and independently verified evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Cedric Duval, Author ID 55941091300. Scopus.
    https://www.scopus.com/pages/authors/55941091300
  2. Journal article. (2026.) Fibrinogen wags its disordered tail: α chain and thrombosis.
    https://doi.org/10.1182/blood.2026033618
  3. ORCID. (n.d.). ORCID record: Cedric Duval, ORCID iD 0000-0002-4870-6542. ORCID.
    https://orcid.org/0000-0002-4870-6542
  4. Cardiology and Cardiovascular Medicine. (2026.). Academic recognition and award information.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Ersilia Nigro | Cardiovascular Researches | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Ersilia Nigro
Università della Campania Vanvitelli, Italy

Ersilia Nigro
Affiliation Università della Campania Vanvitelli
Country Italy
Scopus ID 57194323816
Documents 119
Citations 3,964
h-index 33
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-5637-1685

The Innovative Research Award recognizes the scholarly contributions of Ersilia Nigro, an Italian researcher affiliated with Università della Campania Vanvitelli, whose work has advanced knowledge in cardiovascular and metabolic sciences. Her interdisciplinary research explores adipokines, inflammatory biomarkers, exercise physiology, metabolic dysfunction, and lifestyle-related determinants of cardiovascular health. With an established publication record, a Scopus h-index of 33, and nearly four thousand citations, her investigations have contributed to translational approaches linking molecular mechanisms with clinical practice.[1]

Abstract

This article summarizes the scientific profile of Ersilia Nigro in relation to the Innovative Research Award. Her work integrates molecular cardiology, metabolism, and preventive medicine, emphasizing biomarkers associated with obesity, inflammation, exercise adaptation, and cardiovascular risk. Current research demonstrates sustained engagement with emerging topics including adiponectin signaling, orexin regulation, muscle wasting, and cardiometabolic interventions.[2]

Keywords

Cardiovascular research; adipokines; exercise physiology; obesity; inflammation; cardiometabolic health; translational medicine; biomarkers.

Introduction

Contemporary cardiovascular science increasingly relies on multidisciplinary investigations connecting lifestyle behaviors with molecular pathways. Nigro’s research addresses this need by examining how exercise, nutrition, sleep, and metabolic dysfunction influence cardiovascular outcomes and chronic disease progression.[3]

Research Profile

Her publication portfolio spans clinical, translational, and experimental studies. Indexed in Scopus with 119 documents and 3,964 citations, her scholarship demonstrates sustained influence across cardiovascular medicine, endocrinology, and metabolic research. Collaborative investigations frequently examine biomarker-driven approaches to patient stratification and disease management.[1]

Research Contributions

  • Investigation of adiponectin isoforms and inflammatory biomarkers in chronic diseases.
  • Evaluation of exercise interventions and their effects on cardiometabolic health.
  • Analysis of lifestyle factors, including sleep and nutrition, in cardiovascular regulation.
  • Research on muscle wasting, dyslipidemia, and patient management strategies in chronic respiratory disorders.

Publications

Recent publications include studies on irisin responses in obese middle-aged males, exercise-induced modulation of adiponectin, orexin and lifestyle habits, COPD-associated muscle wasting, and inflammatory markers in Crohn’s disease.[4]

Research Impact

The impact of Nigro’s work is reflected in extensive citation activity and the adoption of biomarker-based approaches within cardiometabolic research. Her studies support evidence-informed strategies for prevention, risk assessment, and personalized interventions targeting obesity-related cardiovascular conditions.[5]

Award Suitability

The Innovative Research Award acknowledges scientific originality, interdisciplinary collaboration, and measurable influence. Nigro’s sustained contributions across cardiovascular medicine, molecular biology, and preventive health align with these criteria through a record of peer-reviewed outputs, translational relevance, and international visibility.[6]

Conclusion

Ersilia Nigro has established a significant research profile at the intersection of cardiovascular science and metabolism. Her investigations continue to inform understanding of biomolecular pathways underlying cardiometabolic disorders while advancing preventive and therapeutic perspectives relevant to contemporary healthcare challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Ersilia Nigro, Author ID 57194323816. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57194323816
  2. Nigro, E., et al. (2026). Effects of Two Different Training Programs on Cardiometabolic Health, Body Composition and Irisin in Middle Age Obese Males: A Pilot Study. Life.
    DOI: https://doi.org/10.3390/life16040657
  3. Nigro, E., et al. (2025). Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases. International Journal of Molecular Sciences.
    DOI: https://doi.org/10.3390/ijms26188980
  4. Nigro, E., et al. (2026). Acute Resistance Exercise Temporarily Reduces Circulating Adiponectin in Trained Young Men: A Pilot Study. Biomolecules. DOI: https://doi.org/10.3390/biom16020229
  5. Nigro, E., et al. (2025). Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13081817
  6. Nigro, E., et al. (2025). Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13020273

Ling Chen | Cardiac Surgery | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Ling Chen | Cardiac Surgery | Best Researcher Award

Dr. Ling Chen, Fujian union hospital, China

Dr. Ling Chen is a renowned cardiac surgeon at Fujian Medical University Affiliated Union Hospital, China. Specializing in aortic dissection, heart valve diseases, and congenital heart defects, Dr. Chen has made significant contributions to cardiovascular surgery. With a strong background in clinical research, Dr. Chen has published in top journals, including Nature Communications. Their work focuses on improving surgical outcomes through innovative techniques like valve-sparing procedures and minimally invasive interventions. Dedicated to advancing cardiac care, Dr. Chen continues to explore novel treatments and biomarkers for cardiovascular diseases, shaping the future of heart surgery in China and beyond.

AUTHOR PROFILE

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Ling Chen’s journey in medicine began at Fujian Medical University, where they pursued a Bachelor’s Degree in Clinical Medicine (2012-2017) . Their deep interest in cardiac surgery led them to earn a Master’s Degree in Surgery (2017-2020) , under the mentorship of Prof. Mingqiang Kang. Driven by a passion for advanced surgical techniques, Dr. Chen completed a Doctorate in Surgery (2020-2023) , under Prof. Liangwan Chen, focusing on groundbreaking cardiovascular research.

🏥 PROFESSIONAL ENDEAVORS:

Currently serving as a Resident Physician in the Department of Cardiac Surgery (August 2023 – Present)  at Fujian Medical University Affiliated Union Hospital, Dr. Chen specializes in:
✔ Aortic Dissection
✔ Aneurysms
✔ Heart Valve Diseases
✔ Coronary Heart Disease
✔ Congenital Heart Defects

Dr. Chen is actively involved in clinical surgeries and research, aiming to improve surgical outcomes through minimally invasive techniques and innovative treatments.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC SURGERY:

Dr. Chen’s research bridges clinical application and scientific discovery, significantly contributing to the field of cardiac surgery and cardiovascular medicine. Their key research areas include:
✅ Pathogenesis of Aortic Dissection – Investigating the underlying mechanisms to improve early diagnosis and treatment.
✅ Factors Influencing Long-Term Prognosis of Minimally Invasive Surgery for Congenital Heart Disease – Enhancing post-surgical outcomes for pediatric and adult patients.

During their tenure at Beijing University School of Basic Medical Sciences (June 2022 – June 2023) , under the mentorship of Prof. Zheng Lemin, Dr. Chen worked on:
✔ Screening and Validation of Novel Biomarkers for Cardiovascular Diseases – Identified potential biomarkers for early cardiovascular disease detection.
✔ Gene Function in Heart Development and Disease – Discovered two new genes linked to heart developmental defects, improving genetic insights into congenital heart conditions.

🌍 IMPACT AND INFLUENCE:

Dr. Chen’s work has far-reaching implications in cardiac surgery and precision medicine:
🔹 Advancing diagnostic tools for cardiovascular diseases using genetic research.
🔹 Improving minimally invasive surgical procedures to enhance patient recovery.
🔹 Integrating biomarker research into clinical applications for early disease detection.

Their dedication to bridging research and clinical practice is helping shape the future of cardiovascular medicine.

📖 ACADEMIC CITES AND PUBLICATIONS:

Dr. Chen’s groundbreaking research has been featured in leading journals, including:
📄 “Propensity Score Matching Analysis of Valve-Sparing Versus Aortic Root Replacement in Type A Aortic Dissection Patients” (Nature Communications, 2025)

This study provides critical insights into optimizing surgical strategies for complex cardiac conditions.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Ling Chen is committed to transforming cardiovascular healthcare through innovation. Their vision for the future includes:
✔ Developing novel surgical approaches to treat heart diseases more effectively.
✔ Expanding research on genetic and molecular mechanisms of cardiovascular disorders.
✔ Enhancing patient outcomes through personalized medicine and advanced diagnostics.

With a strong foundation in surgery, research, and clinical expertise, Dr. Chen continues to pioneer advancements in cardiac surgery, ensuring a lasting impact in the medical field.

🌍CONCLUSION:

Dr. Ling Chen’s dedication to cardiac surgery and research has greatly advanced treatments for aortic dissection, heart valve diseases, and congenital heart defects 🫀. Their expertise in minimally invasive techniques  and commitment to improving patient outcomes have led to groundbreaking contributions in the field. With prestigious publications , innovative surgical techniques , and a passion for discovery, Dr. Chen continues to shape the future of cardiovascular medicine . Their work not only enhances surgical precision  but also paves the way for new advancements , ensuring better healthcare for patients worldwide.

TOP NOTABLE PUBLICATION

“Propensity score matching analysis of valve-sparing versus aortic root replacement in type A aortic dissection patients”:

Authors: Ling Chen, Yichao Pan, Huaijian Zhang, Yi Chen, Chunsheng Wang, Zhihuang Qiu, Heng Lu, Liangwan Chen.

Journal: Nature Communications

Year: 2025

Mojgan Laali | Heart Transplantation | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Mojgan Laali | Heart Transplantation | Best Researcher Award

Dr.Mojgan Laali, Sorbonne university, pitié-Salpêtrière hospital, France

Dr. Mojgan Laali is a highly accomplished cardiovascular surgeon and consultant at Pitié-Salpêtrière Hospital in Paris, France. She holds both an MD and a Ph.D., with her Ph.D. in Electrical Engineering from the Polytechnic Institute of Toulouse. Certified by the French Board of Cardiovascular Surgery in 2008, Dr. Laali is an active member of several prestigious medical societies, including the French and European Societies of Thoracic and Cardiovascular Surgery. Her expertise extends to ECMO and TAVI programs, and she is a professor at the French School of Multi-Organ Harvesting. Throughout her career, she has earned numerous awards, including the Young Investigator Award from the French Society of Cardiac Surgery. Dr. Laali is renowned for her contributions to cardiovascular and thoracic surgery, as well as her commitment to advancing transplantation practices.

Profile:
Scopus Profile 
Education:

 

Dr. Mojgan Laali has an extensive academic background in both medicine and engineering. She earned her certification from the French Board of Cardiovascular Surgery in 2008, following the completion of her AFSA in Cardiac Surgery at Sorbonne University in 2002. In addition to her medical training, Dr. Laali pursued a Ph.D. in Electrical Engineering at the Polytechnic Institute of Toulouse, which she completed between 2007 and 2011, further enhancing her expertise in the integration of engineering principles within cardiovascular surgery.

 

Professional Experience:

 

Dr. Mojgan Laali is a highly regarded cardiovascular surgeon and consultant at Pitié-Salpêtrière Hospital in Paris. She also serves as a professor and member of the French School of Multi-Organ Harvesting (EFPMO) and plays an active role in the Paris ECMO and TAVI programs. Her dedication to innovation and excellence in cardiovascular surgery has made her a key contributor to both clinical practice and medical education, solidifying her reputation as a leader in her field.

 

Research Interests:

Dr. Mojgan Laali’s research focuses on advancing cardiovascular surgery, particularly in thoracic surgery, multi-organ transplantation, and innovative techniques like ECMO (extracorporeal membrane oxygenation) and transcatheter aortic valve implantation (TAVI). Her work aims to improve surgical outcomes and harmonize transplantation practices, making significant contributions to both clinical and research fields in cardiovascular care.
Top Notable Publications:

 

Laali, M., Bouchot, O., Fouquet, O., Lebreton, G., & Leprince, P. (2023). Analysis of a multicenter registry on evaluation of transit-time flow in coronary artery disease surgery. JTCVS Open, 16, 401–418.

Laali, M., Nardone, N., Demondion, P., Lebreton, G., & Leprince, P. (2022). Impact of transit-Time flow measurement on early postoperative outcomes in total arterial coronary revascularization with internal thoracic arteries: A propensity score analysis on 910 patients. Interactive Cardiovascular and Thoracic Surgery, 35(2), ivac065.

Ghavidel, A.A., Mirzaaghayan, M., Yousefnia, M.A., Shirazi, M.N., & Nikpajooh, A. (2020). Iranian society of cardiac surgeons COVID-19 task force version II, restarting elective surgeries. Journal of Cardiovascular and Thoracic Research, 12(3), 158–164.

Petroni, T., D’Alessandro, C., Combes, A., Pavie, A., & Leprince, P. (2019). Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantation. Archives of Cardiovascular Diseases, 112(8-9), 485–493.

Nguyen, L.S., Coutance, G., Salem, J.-E., Leprince, P., & Varnous, S. (2019). Effect of recipient gender and donor-specific antibodies on antibody-mediated rejection after heart transplantation. American Journal of Transplantation, 19(4), 1160–1167.

D’Alessandro, C., Golmard, J.L., Lebreton, G., Vidal, C., & Leprince, P. (2017). High-urgency waiting list for cardiac recipients in France: Single-centre 8-year experience. European Journal of Cardio-thoracic Surgery, 51(2), 271–278.

Kawaguchi, A.T., Collet, J.P., Cluzel, P., Murakami, A., & Leprince, P. (2017). Preoperative Risk Levels and Vascular Access in Transcatheter Aortic Valve Implantation—A Single-Institute Analysis. Artificial Organs, 41(2), 130–138.

Pavie, A., Lebreton, G., Barreda, E., Laali, M., & Leprince, P. (2014). Extra Corporeal Membrane Oxygenation (ECMO): Rupture or continuity. Bulletin de l’Academie Nationale de Medecine, 198(7), 1335–1343.

Bouallouche, S.A., Bouziane, A., Laali, M., Safar, B., & Milleron, O. (2014). Giant left atrial appendage aneurysm. European Heart Journal Cardiovascular Imaging, 15(8), 862.

Pavie, A., Barreda, E., Varnous, S., Leprince, P., & Gangjbakhch., I. (2012). Analysis of 2000 heart transplant procedures at La Pitie Hospital. Bulletin de l’Academie Nationale de Medecine, 196(4-5), 983–996.